Company patents
VERO Biotech Inc.
VERO Biotech Inc. surprisingly shows a strong and sustained focus on "Drug Delivery Devices," accounting for 84.6% of its portfolio, despite a significant decline of 53.8% in 2025 and a further 16.7% decline so far in 2026, suggesting a potential shift in the specific types of devices being patented. Concurrently, "Pharmaceutical Preparations" saw a remarkable 150.0% growth in 2024, indicating an emerging focus on the formulations themselves, even as its "Non-metallic Inorganic Compounds" patents have consistently declined, falling 40.0% so far in 2026.
Patent Trend by Technology Area
Yearly patent publications since 2023
Product themes
Product-level themes inferred from filings since 2023, with category chips showing where each theme appears. Select a theme to filter the patents below.
39 US filings (since 2023) · 6 categories · 3 themes
Systems and devices for delivering gases, aerosols, or pressure support to the respiratory system, often including interfaces like masks and sophisticated control mechanisms for therapeutic effect or airway management.
Delivery systems specifically engineered to administer advanced drug formulations (e.g., microparticles, biologics, extended-release systems) to achieve precise targeting, controlled release kinetics, or enhanced therapeutic efficacy within the body.
Technologies and materials for capturing carbon dioxide from gas streams and subsequently converting it into valuable chemical products or materials, rather than simply storing it.
Patents
Showing 1-10 of 44